Navigation Links
Disruptive Hand Sanitation Product to Save Healthcare Industry Billions

DOVER, N.J., March 17 /PRNewswire/ -- Germgard Lighting LLC, a New Jersey-based, early-phase medical technology company, has patented and demonstrated a revolutionary, ultra-fast, bare-hand sanitation capability. Germgard's technology will lower the cost of care and save lives by curtailing infections resulting from stays in hospitals.

Hospital Acquired Infection places great burden on patients and their families, and undermines the financial well-being of the healthcare delivery system. Indeed, in the U.S. more than 3 million patients acquire an infection during their hospital stay, with more than over $30 billion spent on various aspects of recovery. Despite this enormous expenditure, approximately 100,000 patients die annually as a result of acquiring an infection in a hospital.

According to Germgard CEO Dr. Eugene I. Gordon, "Deployment of our new, efficacious, convenient, and low-cost hand hygiene products will be the least expensive, quickest-to-implement, and most effective solution, allowing hospitals to immediately lower infection rates, reach zero tolerance targets, and properly protect patients and workers."

The ability to inactivate deadly pathogens such as MRSA and C. difficile spores and fully sanitize a nurse's or doctor's bare or gloved hands, in just one second, was absolutely unimaginable only a couple years ago. "Germgard's product is truly disruption innovation," says Cheryl Perkins, President of Innovation Edge, an industry-recognized innovation thought-leader. "Commercialization and implementation of this solution will rapidly change the infection prevention equation in healthcare facilities."

Germgard is positioned to assist hospitals run better, provide higher-quality healthcare, produce improved patient outcomes and save money. The Germgard solution will resolve the persistent issues of speed, hand irritation, and efficacy that have long plagued infection prevention in hospitals, and placed millions of restaurant patrons, cruise ship passengers, and school kids at risk.

Germgard Lighting LLC is funded by and located in a NJ Commission on Science Technology supported innovation incubator on the campus of the U.S. Army Picatinny Arsenal. Its technology pipeline includes hand sanitation, medical instrument sterilization, and air sterilization. The Company represents an excellent example of a public-private partnership creating local jobs and solving critical healthcare delivery problems.

    Media Contact:

    Peter Gordon, VP of Marketing, Germgard Lighting LLC
    (Phone) 973-607-1542
    (FAX) 973-607-1543


This release was issued through eReleases(TM). For more information, visit

SOURCE Germgard Lighting LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Improving Access to Safe Water, Sanitation, Hygiene Requires Better Decision-Making Tools, Finds Joint Wilson Center-Pacific Institute Report
2. Electrolyzed Water Gives Boost to Eliminating Food-Borne Bacteria Such as Salmonella, E. coli and Listeria Murrays Chicken to be First Poultry Processor to Utilize New Technology in its Food Sanitation Process
3. Cleaning Up the Worlds Sanitation
4. Water Advocates Calls for More Drinking Water and Sanitation Projects
5. Project Concern International Receives a US$1 Million Grant From the Starbucks Foundations Ethos Water Fund to Provide Safe Water and Sanitation Services in Tanzania
6. Briggs & Riley Reports That More Travelers Focus on Health and Sanitation This Holiday Season
7. Cooler Solutions Dignity Toilet Wins International Design Competition by Providing Sanitation for Those in Need
8. AWWA, National Association of Water and Sanitation of Mexico, Agree to Share Expertise and Resources for Improved Water Supply
9. Improved Genetic Test Product Empowers Individuals to Better Understand Their Unique Nutritional Needs
10. alli Offers New Wynonna Judd Album in Product Packs
11. Leader in Ear Care Health Category Expands Product Line
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... Lakeview Health, ... country to celebrate their sobriety and show through pictures what a positive difference ... photos this Thanksgiving with the hashtag #FacesOfGratitude on their Facebook, Twitter, and Instagram ...
(Date:11/25/2015)... ... November 25, 2015 , ... On November 23rd 2015 Cozy Products, ... heating products business. Cozy Products explains what this means for business moving forward. , ... the Cozy Products business model: to sell personal heaters that reduce energy consumption, are ...
(Date:11/25/2015)... Livonia, MI (PRWEB) , ... November 25, 2015 , ... ... at Presence Resurrection Medical Center (RMC) in Chicago, IL, UV Angel is evaluating the ... the medical and surgical intensive care units (totaling 30 beds) from May 2014 through ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... found that regular bras were incredibly uncomfortable," said an inventor from Bronx, N.Y. ... , She developed the patent-pending RECOVERY BRA for added comfort and support. The ...
(Date:11/25/2015)... ... , ... Since its launch in 2012, the Regenestem brand ... therapies to patients with chronic degenerative medical conditions. Now, the U.S. Patent and ... , Organizations are required to hold a registered trademark in order to make ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... 24, 2015  Thanks to a donor with a ... Medical Center,s Sister Diane Grassilli Center for Women,s Health ... San Francisco . ... forward with a gift of $617,320 that allowed the ... with Tomosynthesis and Whole Breast Ultrasound. Tomosynthesis, three-dimensional (3-D) ...
(Date:11/24/2015)... , Nov. 24, 2015  Array BioPharma Inc. ... Chief Executive Officer, Ron Squarer , will ... in New York.  The public is welcome to ... the Array BioPharma website.Event:Piper Jaffray Annual Healthcare ConferencePresenter:  ... December 2, 2015Time:1:30 p.m. Eastern Time Webcast: ...
(Date:11/24/2015)... Nov. 24, 2015 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" ... announced today that the first patient has been enrolled ... a treatment for metastatic castration-resistant prostate cancer ("mCRPC"). ... --> the United States ... Phase 1/2 clinical trial, ESSA intends to demonstrate the ...
Breaking Medicine Technology: